Found 19 matching trials
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia EARLY_PHASE1 The main objective of this study is to observe and evaluate the safety and ...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC PHASE2 This study is a phase II, open label, single-arm and exploratory clinical t...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) PHASE3 This is a randomized, controlled, multi-center, phase III clinical study to...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study PHASE3 This study is a prospective, randomized controlled, phase III multicenter t...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT PHASE2 The purpose of this study is to investigate the efficacy and safety of comb...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC PHASE3 Definitive chemoradiotherapy (CRT) is the standard treatment for locally ad...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy PHASE2 The phase II, randomised study is to explore the efficacy and safety of tor...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC PHASE2 This is a single-center, single-arm, phase II clinical study to evaluate th...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC PHASE2 This study is a Phase II study to evaluate the clinical efficacy and safety...
Show More Status
Active Not Recruiting
Location
Chinese Academy of Medical Science and Peking Union Medical College
Learn More & Join Trial
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC PHASE2 Approximately 20 participants will be enrolled in the study to evaluate the...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial